Reduction of Inappropriate Benzodiazepine Prescriptions Among Older Adults Through Direct Patient Education-Reference-Cited by-同舟云学术

Reduction of Inappropriate Benzodiazepine Prescriptions Among Older Adults Through Direct Patient Education

Published:2014-06-01 Issue:6 Volume:174 Page:890
ISSN:2168-6106
Container-title:JAMA Internal Medicine
language:en
Short-container-title:JAMA Intern Med

Author:

Tannenbaum Cara¹,Martin Philippe²,Tamblyn Robyn³,Benedetti Andrea⁴,Ahmed Sara⁵

Affiliation:

1. Faculty of Medicine, Université de Montréal, Montréal, Quebec, Canada2Faculty of Pharmacy, Université de Montréal, Montréal, Quebec, Canada

2. Faculty of Pharmacy, Université de Montréal, Montréal, Quebec, Canada

3. Department of Medicine, McGill University, Montréal, Quebec, Canada4Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montréal, Quebec, Canada

4. Department of Medicine, McGill University, Montréal, Quebec, Canada5The Respiratory Epidemiology and Clinical Research Unit, McGill University Health Centre, Montréal, Quebec, Canada

5. Faculty of Medicine, School of Physical & Occupational Therapy, McGill University, Montréal, Quebec, Canada

Publisher

American Medical Association (AMA)

Subject

Internal Medicine

Cited by 449 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The cost of potentially inappropriate medications for older adults in Canada: A comparative cross‐sectional study;Journal of the American Geriatrics Society;2024-09-05

2. Safe Deprescribing of Benzodiazepines and Z‐drugs;The Maudsley Deprescribing Guidelines – Antidepressants, Benzodiazepines, Gabapentinoids and Z‐drugs;2024-08-30

3. Safe Deprescribing of Gabapentinoids;The Maudsley Deprescribing Guidelines – Antidepressants, Benzodiazepines, Gabapentinoids and Z‐drugs;2024-08-30

4. The effect of deprescribing interventions on mortality and health outcomes in older people: An updated systematic review and meta‐analysis;British Journal of Clinical Pharmacology;2024-08-20

5. Protocol for a type 3 hybrid implementation cluster randomized clinical trial to evaluate the effect of patient and clinician nudges to advance the use of genomic medicine across a diverse health system;Implementation Science;2024-08-19